ACXP — Acurx Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $10.78m
- $4.71m
Annual cashflow statement for Acurx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.6 | -12.7 | -12.1 | -14.6 | -14.1 |
| Non-Cash Items | 2.05 | 7.59 | 3.3 | 3.77 | 3.44 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.801 | 0.141 | 1.25 | 1.01 | 0.284 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.35 | -5.01 | -7.54 | -9.8 | -10.4 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.04 | 14.8 | 3.7 | 8.16 | 6.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.692 | 9.78 | -3.85 | -1.64 | -3.77 |